November 12, 2026 · Fertility and sterility · DOI: 10.1016/j.fertnstert.2026.11.011

Different strategies for medical management before frozen embryo transfer in patients with adenomyosis.

Listen to this summary

This narrative review asks whether medical pretreatment before frozen embryo transfer (FET) improves live birth rates in women with adenomyosis, and which strategies (GnRH agonist, aromatase inhibitors, letrozole, progestins, or oral GnRH antagonists) hold the most promise. The authors found that GnRH agonist pretreatment did not improve live birth in FET meta-analyses or in the one randomized trial, and the overall certainty of evidence is low. They suggest that pooling heterogeneous adenomyosis phenotypes may mask benefit in selected women, such as those with junctional-zone involvement, and call for randomized trials stratified by standardized phenotype.

Mauro Cozzolino, Ilaria Roncarati, Juan Antonio Garcia Velasco

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play